- Adult oncology and haematology prescribing
- Paediatric oncology and haematology prescribing
- Precise drug preparation with customisable worksheets and labels
- Scheduling for treatment and ad-hoc interventions
- Seamless data-sharing between clinical systems
- Potential to treat a higher number of patients due to our unique, integrated scheduling technology
- As well as an ever-increasing range of other product modules and services that assist with informatics, genomics, treatment in care settings away from a hospital and much more.
As a forward-thinking company committed to innovation, CIS Oncology is constantly investing in new technology to ensure the very best products. As a part of continual research and development (R&D), our specialist staff regularly refine and adapt our software ensuring that our systems remain user-friendly, efficient and secure, as well as being fully scalable and robust.
Using an NHS compliant state-of-the-art Cloud-based platform, we have also developed unique software which allows us to integrate 17+ hospitals into a single system.
Years of safer cancer prescribing
Hospitals use the system every day
Records safely stored
What our clients say
Since we went ‘live’ in September 2020, and started the training roll-out, we are pleased with the additional functionality the upgrade has provided. Training has been delivered remotely via software platforms due to social distancing restrictions and this methodology has been efficient and successful. Feedback from end users has been positive and many clinicians prefer the new format.
Lead Cancer Services Pharmacist
Betsi Cadwaladr University Health Board
It has taken significant collaborative effort from all parties to achieve this milestone; we look forward to fully utilising the additional functionality and the upgraded software.
Dr Vikash Dodhia
Senior Site Manager and Business Management Pharmacist
East and North Hertfordshire NHS Trust
Achieving 100% live protocols represents a significant milestone for our team. We're keen to continue to maximise the Dudley Group’s use of the advanced configuration options and functionality available in ChemoCare Version 6.
Interim Principal Pharmacist
Dudley Go Live
We are pleased to announce that Airedale NHS Foundation Trust has now gone live with the planned upgrade to Chemocare V6. The clinical and IT teams at the Trust worked closely with the project team at CIS Oncology to deliver the project within the planned timeframe. The upgraded system will allow us to continue to develop our chemotherapy service and deliver on the new SACT v3 database. We are very happy with the support and project management offered by CIS which meant that the upgrade ran smoothly.
Airedale General Hospital